Tradestie Institutional Equity Comparison Engine
FRSX vs EVGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EVGN Overall Edge
EVGN Captures Institutional Edge (2โ0 Pillars ยท 4โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evogene Ltd. (EVGN) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, FRSX trades at N/M Forward P/E with -2642.2% operating margin (-32.8% YoY revenue) versus EVGN at N/M Forward P/E and -858.2% operating margin (-60.7% YoY). In options structure, FRSX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
FRSX N/M vs EVGN N/M Fwd P/E
Growth & Margin Winner
EVGN
Op Margin -2642.2% vs -858.2% ยท YoY -32.8% vs -60.7%
Momentum & Technical Winner
EVGN
1Y -78.2% vs -71.9% ยท 52W Pos 0% vs 9%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
FRSX
NASDAQ
Foresight Autonomous Holdings Ltd. American Depositary Shares
Services-Prepackaged Software
$0.47
-5.82% 1D
Market Cap
$2.0M
1M Return
-41.73%
1Y Return
-78.19%
Forward P/E
N/M
Unified AI Score
40.4 / 100
SELL
Tech 25.0
Fund 44.0
Flow 50.0
Mom 55.0
EVGN
NASDAQ
Evogene Ltd.
Agricultural Chemicals
$0.34
-13.17% 1D
Market Cap
$6.0M
1M Return
-7.58%
1Y Return
-71.89%
Forward P/E
N/M
Unified AI Score
44.1 / 100
HOLD
Tech 42.0
Fund 44.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
FRSX -78.19%
EVGN -71.89%
Spread: +6.3 pp (EVGN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
FRSX TTM Op. Margin: -2642.2%
EVGN TTM Op. Margin: -858.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FRSX vs EVGN. Trailing 12-month operating profitability (FRSX -2642.2% vs EVGN -858.2%) and valuation multiples (FRSX N/M vs EVGN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FRSX | EVGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.0M | $6.0M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -32.8% | -60.7% | Higher Growth | FRSX |
| Operating Margin (TTM) Profitability | -2642.2% | -858.2% | Higher Margin | EVGN |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -205.9% | -182.8% | Higher ROE | EVGN |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 9% ($0โ$1) | Stronger Trend | EVGN |
| Beta / 30D Volatility Risk Regime | 1.23ฮฒ ยท 57% Vol | 1.37ฮฒ ยท 138% Vol | Lower Realized Risk | FRSX |
| Unified Institutional Score Composite Signal | 40.4 / 100 (SELL) | 44.1 / 100 (HOLD) | Higher Composite | EVGN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full FRSX vs EVGN Buy Guide
FRSX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
EVGN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither FRSX nor EVGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.